Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Funded projects

The following projects were funded by the Medical and Life Sciences Translational Fund in April 2025:

 

  • Implementation of phase-targeted deep brain stimulation using a human device - Sharott, Andrew (Clinical Neurosciences)
  • Creation of a stimulation device for use within the Smart Infant Monitoring System (SIMS) platform to measure pain in preterm babies - Slater, Rebeccah (Paediatrics)
  • Preclinical assessment of a promising RNA editor for CRB1 gene therapy  - MacLaren, Robert (Clinical Neurosciences)
  • LGI1 gene therapy for the treatment of neuropathic pain - Dawes, John (Clinical Neurosciences)
  • A novel malaria diagnostics for community health care with optical imaging of hemozoin - Berry, Richard (Physics)
  • Pandemic preparedness: Development of a point-of-care rapid test for diagnosing Henipaviruses - Adams, Emily (Pandemic Sciences Institute)
  • Identifying falsified vaccines using a series of repurposed low-cost tests for use in low- and middle-income countries (LMIC) - Zitzmann, Nicole (Biochemistry)
  • Enhancing the efficacy of therapeutic oligonucleotides by new synergistic chemical modifications - Brown, Thomas  (Chemistry)
  • Development of novel hypoxia-modifying drugs for cancer treatment - Higgins, Geoffrey (Oncology)
  • Establishing biomarkers to predict patient drug response in inflammatory bowel disease - Dendrou, Calliope (NDORMS – Kennedy)
  • Evaluation of Carrier Systems to Enhance the Efficacy of Therapeutic Oligonucleotides – Frommer (Jennifer, Paediatrics)
  • Preclinical development of influenza neuraminidase vaccine - Rijal, Pramila (RDM Investigative Medicine)
  • Maternal mitochondria transfer as a novel therapy for treatment of Fetal Growth Restriction - Kandzija, Neva (Women’s and Reproductive Health)
  • Raiden: AI powered platform for RNA-drug discovery - Gullerova, Monika (Pathology Dunn School)
  • Pre-clinical optimisation of an Immune Stimulating Ultrasound Responsive Drug Delivery Platform Technology - Lyons, Brian (Engineering Science)
In this section